175 results on '"Halder, Amit Kumar"'
Search Results
2. Pharmacovigilance of Herbal Medicines for Lifestyle Diseases
3. Role of Natural Polysaccharides in the Management of Lifestyle Diseases
4. Herbal Medicines for the Treatment of Liver Cirrhosis
5. SMILES-Based Bioactivity Descriptors to Model the Anti-dengue Virus Activity: A Case Study
6. Finding structural requirements of structurally diverse α-glucosidase and α-amylase inhibitors through validated and predictive 2D-QSAR and 3D-QSAR analyses
7. Predicting the ecotoxicity of endocrine disruptive chemicals: Multitasking in silico approaches towards global models
8. Multi-model in silico characterization of 3-benzamidobenzoic acid derivatives as partial agonists of Farnesoid X receptor in the management of NAFLD
9. Analgesic and Anti-inflammatory Activities of Trayodashang Guggulu, an Ayurvedic Formulation
10. Turning deep-eutectic solvents into value-added products for CO2 capture: A desirability-based virtual screening study
11. Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms
12. Shaping the Future of Obesity Treatment: In Silico Multi-Modeling of IP6K1 Inhibitors for Obesity and Metabolic Dysfunction
13. Structural insights into the interactions of repositioning and known drugs for Alzheimer’s disease with hen egg white lysozyme by MM-GBSA
14. QSAR-Co-X: an open source toolkit for multitarget QSAR modelling
15. Molecular alteration in drug susceptibility against subtype B and C-SA HIV-1 proteases: MD study
16. Finding structural requirements of structurally diverse α-glucosidase and α-amylase inhibitors through validated and predictive 2D-QSAR and 3D-QSAR analyses
17. In Silico Modeling and Structural Analysis of Soluble Epoxide Hydrolase Inhibitors for Enhanced Therapeutic Design
18. Benzamide porphyrins with directly conjugated and distal pyridyl or pyridinium groups substituted to the porphyrin macrocycles: Study of the photosensitising abilities as inducers of apoptosis in cancer cells under photodynamic conditions
19. Designing multi-target drugs for the treatment of major depressive disorder
20. Genetic algorithm-de novo, molecular dynamics and MMGBSA based modelling of a novel Benz-pyrazole based anticancer ligand to functionally revert mutant P53 into wild type P53
21. Predicting the Ecotoxicity of Endocrine Disruptive Chemicals: Multitasking in Silico Approaches Towards Global Models
22. Genetic algorithm-de novo, molecular dynamics and MMGBSA based modelling of a novel Benz-pyrazole based anticancer ligand to functionally revert mutant P53 into wild type P53
23. Structural findings of phenylindoles as cytotoxic antimitotic agents in human breast cancer cell lines through multiple validated QSAR studies
24. Advanced Chemometric Modeling Approaches for the Design of Multitarget Drugs Against Neurodegenerative Diseases
25. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents
26. Possible anticancer agents: synthesis, pharmacological activity, and molecular modeling studies on some 5-N -Substituted-2-N-(substituted benzenesulphonyl)-L(+)Glutamines
27. A Step Forward in the Use of Greener Solvents
28. In silico characterization of aryl benzoyl hydrazide derivatives as potential inhibitors of RdRp enzyme of H5N1 influenza virus
29. Predicting the Surface Tension of Deep Eutectic Solvents: A Step Forward in the Use of Greener Solvents
30. Ligand- and Structure-Based Drug Design of Non-Steroidal Aromatase Inhibitors (NSAIs) in Breast Cancer
31. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols
32. Moving Average-Based Multitasking In Silico Classification Modeling: Where Do We Stand and What Is Next?
33. First multi-target QSAR model for predicting the cytotoxicity of acrylic acid-based dental monomers
34. Synthesis, anticancer activity, SAR and binding mode of interaction studies of substituted pentanoic acids: part II
35. Modelling and molecular dynamics simulation of novel anticancer ligand for restructuring mutant P53 into wild type
36. Modelling and molecular dynamics simulation of novel anticancer ligand for restructuring mutant P53 into wild type
37. Multi-Target In Silico Prediction of Inhibitors for Mitogen-Activated Protein Kinase-Interacting Kinases
38. Chemometric Modeling of Daphnia Toxicity
39. Structural findings of cinnolines as anti-schizophrenic PDE10A inhibitors through comparative chemometric modeling
40. Structural findings of quinolone carboxylic acids in cytotoxic, antiviral, and anti-HIV-1 integrase activity through validated comparative molecular modeling studies
41. Exploring structural requirements of aurone derivatives as antimalarials by validated DFT-based QSAR, HQSAR, and COMFA–COMSIA approach
42. Ligand- and Structure-Based Drug Design of Non-Steroidal Aromatase Inhibitors (NSAIs) in Breast Cancer
43. Synthesis, pharmacological activity and comparative QSAR modeling of 1,5- N, N′-substituted-2-(substituted naphthalenesulphonyl) glutamamides as possible anticancer agents
44. Density of Deep Eutectic Solvents: The Path Forward Cheminformatics-Driven Reliable Predictions for Mixtures
45. QSAR modelling of pancreatic β-cell K ATP channel openers R/ S-3,4-dihydro-2,2-dimethyl-6-halo-4-(substituted phenylaminocarbonylamino)-2 H-1-benzopyrans using MLR–FA techniques
46. Additional file 1 of QSAR-Co-X: an open source toolkit for multitarget QSAR modelling
47. Epstein–Barr Virus and Treatment of Its Infection
48. AKT Inhibitors: The Road Ahead to Computational Modeling-Guided Discovery
49. Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors
50. Synthesis, biological evaluation, and enzyme assay of some 5-N-substituted-2-N- (arylsulphonyl)-L(+)glutamines as potential anticancer agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.